Kevin Gardinier

Vice President Discovery Research at Karuna Therapeutics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Arlington, Massachusetts, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology
    • 100 - 200 Employee
    • Vice President Discovery Research
      • Sep 2021 - Present

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director of Medicinal Chemistry - Neuroscience and Nephrology
      • Oct 2016 - Sep 2021

      - Portfolio responsibilities across neuroscience and nephrology to shape scientific strategy, manage resources, and develop talent. - Experienced leader with excellent cross-functional collaboration skills focused on establishing an integrated scientific strategy from target identification through lead optimization. - Developed a multi-dimensional Targeted Protein Degradation (TPD) approach to treat CNS proteinopathies. - Portfolio responsibilities across neuroscience and nephrology to shape scientific strategy, manage resources, and develop talent. - Experienced leader with excellent cross-functional collaboration skills focused on establishing an integrated scientific strategy from target identification through lead optimization. - Developed a multi-dimensional Targeted Protein Degradation (TPD) approach to treat CNS proteinopathies.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Research Advisor and Neuroscience Group Leader
      • Feb 2000 - Sep 2016

      Extensive lead generation and optimization experience in neuroscience research focused on neurodegenerative diseases (tau pathology), ligand-gated and voltage-gated ion channel targets for the treatment of epilepsy and pain, and on cell surface targets to treat diseases related to obesity and anxiety/depression. Extensive lead generation and optimization experience in neuroscience research focused on neurodegenerative diseases (tau pathology), ligand-gated and voltage-gated ion channel targets for the treatment of epilepsy and pain, and on cell surface targets to treat diseases related to obesity and anxiety/depression.

    • Research Assistant
      • Jun 1994 - Aug 1994

      Synthesized linkers for combinatorial chemistry. Developed novel 3-dimensional support linkers. Synthesized linkers for combinatorial chemistry. Developed novel 3-dimensional support linkers.

Education

  • University of California, Berkeley
    Ph.D., Organic Synthesis, Natural Products
    1994 - 1998
  • Université Louis Pasteur (Strasbourg I)
    Post-Doc with Nobel Laureate Jean-Marie Lehn, Synthetic Chemistry, Molecular Recognition
    1998 - 2000
  • Colgate University
    Bachelor of Arts (B.A.), Organic Chemistry
    1990 - 1994

Community

You need to have a working account to view this content. Click here to join now